| 0 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
13 |
0.0232 |
| 1 |
ANORECTAL CELLULITIS |
1 |
0.0164 |
| 2 |
HEPATIC ENZYME |
2 |
0.0134 |
| 3 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
15 |
0.0072 |
| 4 |
X-RAY ABNORMAL |
12 |
0.0067 |
| 5 |
DISLOCATION OF VERTEBRA |
15 |
0.0066 |
| 6 |
HYPOCHOLESTEROLAEMIA |
2 |
0.0057 |
| 7 |
SWOLLEN JOINT COUNT INCREASED |
13 |
0.0041 |
| 8 |
PUSTULAR PSORIASIS |
14 |
0.0041 |
| 9 |
RHEUMATIC FEVER |
15 |
0.0034 |
| 10 |
RASH VESICULAR |
14 |
0.0029 |
| 11 |
RHEUMATOID FACTOR POSITIVE |
13 |
0.0022 |
| 12 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
14 |
0.0022 |
| 13 |
GRIP STRENGTH DECREASED |
18 |
0.0020 |
| 14 |
WALKING AID USER |
13 |
0.0020 |
| 15 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
14 |
0.0020 |
| 16 |
DUODENAL ULCER PERFORATION |
14 |
0.0019 |
| 17 |
MUSCLE INJURY |
15 |
0.0018 |
| 18 |
BREAST CANCER STAGE II |
15 |
0.0018 |
| 19 |
HYPERCHOLESTEROLAEMIA |
17 |
0.0018 |
| 20 |
GENERAL SYMPTOM |
13 |
0.0017 |
| 21 |
HELICOBACTER INFECTION |
17 |
0.0017 |
| 22 |
LUPUS VULGARIS |
2 |
0.0016 |
| 23 |
MYOSITIS |
14 |
0.0016 |
| 24 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
3 |
0.0015 |
| 25 |
FOLLICULITIS |
15 |
0.0014 |
| 26 |
HAND DEFORMITY |
17 |
0.0013 |
| 27 |
GLIOBLASTOMA MULTIFORME |
1 |
0.0012 |
| 28 |
WOUND INFECTION |
13 |
0.0012 |
| 29 |
PEMPHIGUS |
14 |
0.0011 |
| 30 |
C-REACTIVE PROTEIN |
1 |
0.0011 |
| 31 |
JOINT RANGE OF MOTION DECREASED |
14 |
0.0010 |
| 32 |
PERICARDITIS |
15 |
0.0009 |
| 33 |
BACK DISORDER |
14 |
0.0009 |
| 34 |
GLOSSODYNIA |
18 |
0.0008 |
| 35 |
HIP ARTHROPLASTY |
12 |
0.0008 |
| 36 |
PULMONARY FIBROSIS |
15 |
0.0008 |
| 37 |
SYNOVITIS |
13 |
0.0007 |
| 38 |
IRRITABLE BOWEL SYNDROME |
15 |
0.0007 |
| 39 |
PORPHYRIA ACUTE |
1 |
0.0007 |
| 40 |
EYE INJURY |
2 |
0.0007 |
| 41 |
IMPAIRED HEALING |
20 |
0.0006 |
| 42 |
DISABILITY |
12 |
0.0006 |
| 43 |
FIBROMYALGIA |
14 |
0.0006 |
| 44 |
LIVER INJURY |
14 |
0.0006 |
| 45 |
KNEE ARTHROPLASTY |
12 |
0.0006 |
| 46 |
PERIPHERAL VENOUS DISEASE |
2 |
0.0005 |
| 47 |
ONYCHOMADESIS |
2 |
0.0005 |
| 48 |
GAIT INABILITY |
15 |
0.0004 |
| 49 |
DELIRIUM |
15 |
0.0004 |
| 50 |
WOUND |
12 |
0.0004 |
| 51 |
TYPE 2 DIABETES MELLITUS |
14 |
0.0004 |
| 52 |
EYE OEDEMA |
1 |
0.0004 |
| 53 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
14 |
0.0004 |
| 54 |
APLASTIC ANAEMIA |
2 |
0.0004 |
| 55 |
PSORIATIC ARTHROPATHY |
15 |
0.0004 |
| 56 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 57 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 58 |
LOWER RESPIRATORY TRACT INFECTION |
15 |
0.0003 |
| 59 |
ILL-DEFINED DISORDER |
20 |
0.0003 |
| 60 |
C-REACTIVE PROTEIN ABNORMAL |
2 |
0.0003 |
| 61 |
FACET JOINT SYNDROME |
1 |
0.0003 |
| 62 |
BLOOD CHOLESTEROL INCREASED |
14 |
0.0003 |
| 63 |
BONE EROSION |
1 |
0.0003 |
| 64 |
OEDEMA |
15 |
0.0003 |
| 65 |
FLUID RETENTION |
14 |
0.0003 |
| 66 |
BLISTER |
15 |
0.0003 |
| 67 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 68 |
ARTHROPATHY |
14 |
0.0003 |
| 69 |
HEPATIC ENZYME INCREASED |
17 |
0.0002 |
| 70 |
BLEPHARITIS |
1 |
0.0002 |
| 71 |
STOMATITIS |
15 |
0.0002 |
| 72 |
DISCOMFORT |
15 |
0.0002 |
| 73 |
WHEEZING |
14 |
0.0002 |
| 74 |
AMNESIA |
15 |
0.0002 |
| 75 |
INJURY |
16 |
0.0002 |
| 76 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 77 |
GASTROINTESTINAL DISORDER |
19 |
0.0002 |
| 78 |
INFUSION RELATED REACTION |
14 |
0.0002 |
| 79 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 80 |
SLEEP DISORDER |
14 |
0.0002 |
| 81 |
MOBILITY DECREASED |
14 |
0.0002 |
| 82 |
NORMAL NEWBORN |
1 |
0.0002 |
| 83 |
BACK INJURY |
2 |
0.0002 |
| 84 |
ASTHENOPIA |
1 |
0.0002 |
| 85 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 86 |
CONTUSION |
16 |
0.0002 |
| 87 |
BURSITIS |
2 |
0.0002 |
| 88 |
MUSCULOSKELETAL STIFFNESS |
14 |
0.0002 |
| 89 |
BLEPHAROSPASM |
1 |
0.0002 |
| 90 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 91 |
PROCTALGIA |
1 |
0.0002 |
| 92 |
BREAST CANCER STAGE III |
1 |
0.0002 |
| 93 |
TASTE DISORDER |
3 |
0.0001 |
| 94 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 95 |
GENERAL PHYSICAL HEALTH DETERIORATION |
17 |
0.0001 |
| 96 |
MIGRAINE |
14 |
0.0001 |
| 97 |
DYSPEPSIA |
14 |
0.0001 |
| 98 |
LYMPHOPENIA |
2 |
0.0001 |
| 99 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 100 |
SWELLING |
13 |
0.0001 |
| 101 |
SINUSITIS |
14 |
0.0001 |
| 102 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 103 |
SCIATICA |
2 |
0.0001 |
| 104 |
LIVE BIRTH |
1 |
0.0001 |
| 105 |
JOINT SWELLING |
14 |
0.0001 |
| 106 |
RHEUMATOID ARTHRITIS |
13 |
0.0001 |
| 107 |
NAIL DISORDER |
1 |
0.0001 |
| 108 |
INFECTION |
16 |
0.0001 |
| 109 |
LUPUS-LIKE SYNDROME |
1 |
0.0001 |
| 110 |
LIP DRY |
1 |
0.0001 |
| 111 |
EXOSTOSIS |
1 |
0.0001 |
| 112 |
BREAST CANCER STAGE I |
1 |
0.0001 |
| 113 |
PSORIASIS |
14 |
0.0001 |
| 114 |
LEUKAEMIA |
1 |
0.0001 |
| 115 |
PERIPHERAL SWELLING |
16 |
0.0001 |
| 116 |
EAR PAIN |
2 |
0.0001 |
| 117 |
HAEMORRHOIDS |
2 |
0.0001 |
| 118 |
MEMORY IMPAIRMENT |
14 |
0.0001 |
| 119 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 120 |
HYPERSENSITIVITY |
18 |
0.0001 |
| 121 |
HYPOAESTHESIA |
14 |
0.0001 |
| 122 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 123 |
CONFUSIONAL STATE |
15 |
0.0001 |
| 124 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 125 |
FOOT DEFORMITY |
1 |
0.0001 |
| 126 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 127 |
URTICARIA |
15 |
0.0001 |
| 128 |
ALOPECIA |
17 |
0.0001 |
| 129 |
HYPERTENSION |
18 |
0.0001 |
| 130 |
ABDOMINAL DISCOMFORT |
14 |
0.0001 |
| 131 |
CHEST PAIN |
15 |
0.0001 |
| 132 |
JOINT STIFFNESS |
2 |
0.0001 |
| 133 |
NASOPHARYNGITIS |
14 |
0.0001 |
| 134 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 135 |
DECREASED APPETITE |
17 |
0.0001 |
| 136 |
GAIT DISTURBANCE |
14 |
0.0001 |
| 137 |
OSTEOARTHRITIS |
3 |
0.0001 |
| 138 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 139 |
ANOSMIA |
1 |
0.0001 |
| 140 |
ABDOMINAL PAIN UPPER |
14 |
0.0001 |
| 141 |
OBESITY |
1 |
0.0001 |
| 142 |
WEIGHT INCREASED |
14 |
0.0001 |
| 143 |
DEPRESSION |
14 |
0.0001 |
| 144 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 145 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 146 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 147 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 148 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 149 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 150 |
PREGNANCY |
1 |
0.0000 |
| 151 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 152 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 153 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 154 |
PAIN IN EXTREMITY |
14 |
0.0000 |
| 155 |
WEIGHT DECREASED |
13 |
0.0000 |
| 156 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 157 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 158 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 159 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 160 |
PYREXIA |
15 |
0.0000 |
| 161 |
PNEUMONIA |
14 |
0.0000 |
| 162 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 163 |
PRURITUS |
15 |
0.0000 |
| 164 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 165 |
INFLAMMATION |
2 |
0.0000 |
| 166 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 167 |
EAR INFECTION |
1 |
0.0000 |
| 168 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 169 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 170 |
MEDICATION ERROR |
2 |
0.0000 |
| 171 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 172 |
RASH |
15 |
0.0000 |
| 173 |
MALAISE |
15 |
0.0000 |
| 174 |
ARTHRALGIA |
14 |
0.0000 |
| 175 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 176 |
EPILEPSY |
1 |
0.0000 |
| 177 |
ADVERSE EVENT |
3 |
0.0000 |
| 178 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 179 |
NIGHT SWEATS |
1 |
0.0000 |
| 180 |
HEADACHE |
19 |
0.0000 |
| 181 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 182 |
DYSPNOEA |
17 |
0.0000 |
| 183 |
EYE PRURITUS |
1 |
0.0000 |
| 184 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 185 |
VOMITING |
13 |
0.0000 |
| 186 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 187 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 188 |
ASTHMA |
3 |
0.0000 |
| 189 |
PAIN |
16 |
0.0000 |
| 190 |
OSTEOPOROSIS |
1 |
0.0000 |
| 191 |
DIARRHOEA |
15 |
0.0000 |
| 192 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 193 |
LIVER DISORDER |
1 |
0.0000 |
| 194 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 195 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 196 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 197 |
FATIGUE |
17 |
0.0000 |
| 198 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 199 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 200 |
LUNG DISORDER |
1 |
0.0000 |
| 201 |
DRY EYE |
1 |
0.0000 |
| 202 |
CELLULITIS |
1 |
0.0000 |
| 203 |
NECK PAIN |
1 |
0.0000 |
| 204 |
NAUSEA |
14 |
0.0000 |
| 205 |
EYE IRRITATION |
1 |
0.0000 |
| 206 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 207 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 208 |
FEELING HOT |
1 |
0.0000 |
| 209 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 210 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 211 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 212 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 213 |
UNDERDOSE |
1 |
0.0000 |
| 214 |
BRONCHITIS |
1 |
0.0000 |
| 215 |
EPISTAXIS |
1 |
0.0000 |
| 216 |
HOSPITALISATION |
2 |
0.0000 |
| 217 |
ARTHRITIS |
1 |
0.0000 |
| 218 |
PARAESTHESIA |
2 |
0.0000 |
| 219 |
THROMBOSIS |
1 |
0.0000 |
| 220 |
DRY MOUTH |
1 |
0.0000 |
| 221 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 222 |
TREATMENT FAILURE |
1 |
0.0000 |
| 223 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 224 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 225 |
ANXIETY |
3 |
0.0000 |
| 226 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 227 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 228 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 229 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 230 |
INSOMNIA |
2 |
0.0000 |
| 231 |
DEHYDRATION |
1 |
0.0000 |
| 232 |
VISION BLURRED |
1 |
0.0000 |
| 233 |
OFF LABEL USE |
5 |
0.0000 |
| 234 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 235 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 236 |
MUSCLE SPASMS |
1 |
0.0000 |
| 237 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 238 |
FALL |
1 |
0.0000 |
| 239 |
ASTHENIA |
1 |
0.0000 |
| 240 |
DEATH |
2 |
0.0000 |
| 241 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 242 |
DIZZINESS |
1 |
0.0000 |